[Nicotinic acid in lipid metabolism disorders].
Ahmed
Kashan
K
Institut für Pharmakologie, Medizinische Fakultät, Universität Heidelberg.
Offermanns
Stefan
S
D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D000960:Hypolipidemic Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D052439:Lipid Metabolism Disorders / Q000188:drug therapy*; D009525:Niacin / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D011978:Receptors, Nicotinic / Q000187:drug effects
D000960:Hypolipidemic Agents; D011978:Receptors, Nicotinic; D009525:Niacin